Avian Influenza Vaccines Market

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Avian Influenza Vaccines Market contains market size and forecasts of Avian Influenza Vaccines in global, including the following market information:

Global Avian Influenza Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Avian Influenza Vaccines Market Sales, 2017-2022, 2023-2028, (M Doses)

Global top five Avian Influenza Vaccines companies in 2021 (%)

The global Avian Influenza Vaccines market was valued at 976.5 million in 2021 and is projected to reach US$ 1398.3 million by 2028, at a CAGR of 5.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

H5+H7 Avian Influenza Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Avian Influenza Vaccines include Merial, QYH Biotech, DHN, HVRI, CEVA, Elanco (Lohmann ), Yebio, Zoetis and FATRO, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Avian Influenza Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Avian Influenza Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Avian Influenza Vaccines Market Segment Percentages, by Type, 2021 (%)

H5+H7 Avian Influenza Vaccines

H9 Avian Influenza Vaccines

Global Avian Influenza Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Avian Influenza Vaccines Market Segment Percentages, by Application, 2021 (%)

Chicken Avian Influenza Vaccines

Duck & Goose Avian Influenza Vaccines

Other

Global Avian Influenza Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Avian Influenza Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Avian Influenza Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Avian Influenza Vaccines revenues share in global market, 2021 (%)

Key companies Avian Influenza Vaccines sales in global market, 2017-2022 (Estimated), (M Doses)

Key companies Avian Influenza Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Merial

QYH Biotech

DHN

HVRI

CEVA

Elanco (Lohmann )

Yebio

Zoetis

FATRO

Kyoto Biken

CAVAC

Ringpu Biology

Vaksindo

ChengDu Tecbond

Sindh Poultry Vaccine Centre

Merck Animal Health

Medion

Avimex Animal Health

JOVAC

Bio-Labs